Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) EBITDA (2024 - 2025)

Beta Bionics' EBITDA history spans 2 years, with the latest figure at -$13.4 million for Q4 2025.

  • For Q4 2025, EBITDA rose 25.88% year-over-year to -$13.4 million; the TTM value through Dec 2025 reached -$72.9 million, down 32.89%, while the annual FY2025 figure was -$72.9 million, 32.89% down from the prior year.
  • EBITDA for Q4 2025 was -$13.4 million at Beta Bionics, up from -$14.0 million in the prior quarter.
  • Across five years, EBITDA topped out at -$9.7 million in Q3 2024 and bottomed at -$28.5 million in Q1 2025.